|
|
|
Home >
Health Condition > Alzheimer's Disease
> Memantine
Namenda/Axura (memantine)
Related Topics:
News & Research:
-
Effects of Memantine and
High Dose Vitamin D on Gait in Male APP/PS1 Alzheimer's Disease Mice Following
Vitamin D Deprivation - J Alzheimers Dis 2021 Dec 22 -
"Vitamin D deprivation led to impaired postural control
in the APPswe/PS1dE9 model. Treatment with memantine and vitamin D, but not
memantine alone, prevented this impairment" - See vitamin D at Amazon.com.
-
Vitamin E Improves
Function in Mild Alzheimer's Disease - Medscape, 12/31//13 -
"The study, conducted at 14 Veterans Affairs medical
centers, assessed the effect of vitamin E alone or with memantine on
functional decline in 613 patients (97% men) with mild to moderate AD ... By
random assignment, 152 patients received 2000 IU of α-tocopherol per day,
155 received 20 mg of memantine per day, 154 received the combination of
vitamin E and memantine, and 152 received placebo. They were followed for a
mean of 2.3 years ... The annual rate of decline in ADLs was reduced by 19%
(P = .03) with vitamin E compared with placebo" - [Science
Daily] [Abstract]
- Note: I'm
still sticking with the mixed form of vitamin E. See
Jarrow FamilE (contains all eight members of the vitamin E family, includes
Tocomin) at Amazon.com
 .
-
Alzheimer's drug fails to reduce significant agitation - Science Daily,
5/2/12
-
Why
Alzheimer's drug is both safe and effective, study explains - Science
Daily, 8/18/10
-
Benefit Of Memantine In The Treatment Of Alzheimer's Disease Not Proven
- Science Daily, 10/28/09
-
Memantine And Alzheimer's Disease - Science Daily, 1/10/08
-
Memantine Demonstrates Good Safety Profile and Cognitive and Functional
Performance in Treatment of Moderate-to-Severe Alzheimer's Disease -
Doctor's Guide, 8/30/07
-
There's Hope in the Drug Pipeline [for Alzheimer's] - US News, 12/11/06
- "A compound called huperzine A seems to combine
some memory-saving effects of drugs like Aricept and Namenda with an ability
to protect neurons from beta amyloid. It's currently being tested for safety
and effectiveness in people" - See
iHerb
or
Vitacost
huperzine A products.
-
Treatment Benefits Are Ongoing When Patients With Moderate to Severe
Alzheimer's Disease Receive Memantine While Continuing Donepezil -
Doctor's Guide, 10/12/06
-
Behavior Problems in Moderate to Severe Alzheimer's Disease Improved With
Combined Memantine and Donepezil - Doctor's Guide, 10/10/06
-
Cognitive Benefits Continue in Patients with Mild to Moderate Alzheimer's
Disease Treated With Memantine - Doctor's Guide, 10/10/06
-
Memantine Can Provide Behavioural Mood and Psychosis Benefits in Patients
With Alzheimer's Disease - Doctor's Guide, 9/22/06
-
Memantine Improves Behavioural Symptoms in Patients With Moderate to Severe
Alzheimer's Disease - Doctor's Guide, 9/7/06
-
Follow-up Study Shows Drug Slows Severe Alzheimer's Symptoms For One Year
- Science Daily, 1/27/06
-
Memantine Appears Effective And Safe In Moderate To Severe Alzheimer's
Disease - Science Daily, 1/25/06
-
Memantine May Be Beneficial for Alzheimer Disease - Medscape, 1/23/06
-
Findings Indicate Continuing Benefits Over 1 Year in Subjects Receiving
Namenda (Memantine) - Doctor's Guide, 1/11/06
-
Drug Slows Alzheimer's Disease - WebMD, 1/9/06
-
Ebixa (memantine) Demonstrates Longer Term Benefits for Moderate to Severe
Alzheimer's Disease Patients - Doctor's Guide, 1/9/06
-
Studies Find Memantine Treatment Improves Specific Symptoms of Alzherimer's
Disease - Doctor's Guide, 10/26/05
-
Ebixa, Extended Approval for Treatment of Moderate Alzheimer's Disease -
Doctor's Guide, 10/17/05
-
Oral Solution Formulation of Namenda (Memantine HCl), the Only FDA-Approved
Oral Solution for Moderate to Severe Alzheimer's Disease, Now Available
- Doctor's Guide, 8/19/05
-
Memantine (Namenda) Effective for Behavioral Symptoms in Patients With
Mild-to-Severe Alzheimer's Disease - Doctor's Guide, 5/31/05
-
Memantine Reduces Behavioral Symptoms Associated with Alzheimer's Disease
- Doctor's Guide, 4/13/05
-
Memantine May Reduce Agitation in AD Patients - Clinical Psychiatry
News, 4/05
-
Ebixa (Memantine) Promising Treatment for Alzheimer's Disease - Doctor's
Guide, 3/14/05
-
Memantine's Benefits May Extend to Earlier Stages of Alzheimer's Disease
- Doctor's Guide, 10/8/04
-
Memantine Shows Efficacy for Mild To Moderate AD in Phase III Study -
Clinical Psychiatry News, 9/04
- Memantine May Be
Effective for Mild to Moderate Alzheimer's Disease - Medscape, 7/21/04
-
Memantine Also Effective in Mild To Moderate Alzheimer's Disease -
Clinical Psychiatry News, 7/04
-
Memantine Improves Cognition in Alzheimer's - Clinical Psychiatry News,
7/04
-
Memantine + Stable Acetylcholinesterase Inhibitor Provides Benefits to
Alzheimer's Disease Patients - Doctor's Guide, 4/30/04
-
Namenda (Memantine) Appears to Produce Positive Effect on Brain Activity In
Patients With Mild to Moderate Alzheimer's Disease - Doctor's Guide,
4/28/04
-
Memantine Monotherapy Useful for Alzheimer' Disease - Doctor's Guide,
4/27/04
-
Namenda (Memantine) Shows Benefit in Behavioral Disturbances Associated With
Moderate to Severe Alzheimer's Disease - Doctor's Guide, 2/24/04
-
Memantine More Effective Than Placebo for Treatment of Alzheimer Disease in
Patients Receiving Donepezil - Doctor's Guide, 1/21/04
- Drug Combo
Slows Alzheimer's Disease - WebMD, 1/20/04
-
First Drug for Advanced Alzheimer's Approved - Clinical Psychiatry News
Online, 11/03
-
FDA Approves Namenda (Memantine HCl) for Treatment of Moderate to Severe
Alzheimer's Disease - Doctor's Guide, 10/17/03 -
"Namenda is the first NMDA receptor antagonist to be
approved for Alzheimer's disease and is also the only therapy approved for
the treatment of moderate to severe Alzheimer's disease ... Namenda will be
available in pharmacies in January 2004"
-
Memantine Provides Functional Improvement for Advanced Alzheimer's Patients
- Doctor's Guide, 10/14/03
-
Panel Backs Memantine for Moderate, Severe Alzheimer's - Clinical
Psychiatry News, 10/03
-
FDA Advisory Committee Recommends Approval for Namenda (Memantine HCl) For
Moderate to Severe Alzheimer's Disease - Doctor's Guide, 9/25/03
-
FDA Advisers Evaluate Alzheimer's Drug - Intelihealth, 9/24/03
-
Memantine Plus Donepezil Effective for Severe AD - Clinical Psychiatry
News, 8/03
-
Start Cholinesterase Inhibitor Immediately After Alzheimer's Dx -
Clinical Psychiatry News, 6/03
-
Memantine Adds Benefits to Donepezil Therapy in Alzheimer's Patients -
Doctor's Guide, 5/21/03
- New
Drug [memantine] Offers Hope As Alzheimer’s Treatment - Psychiatric
News, 5/2/03
-
Memantine Can Cut Alzheimer's-Related Costs - Clinical Psychiatry News,
5/03
-
Memantine Curbs Decline In Alzheimer's Patients - Doctor's Guide, 4/3/03
-
Drug Slows Progression of Alzheimer's - HealthDay, 4/2/03
- Memantine Shows
Promise in Treating Advanced Alzheimer's Disease - WebMD, 4/1/03
-
Drug for Severe Alzheimer's Disease [Memantine] Is Heading to U.S -
Clinical Psychiatry News, 9/02
-
Cognitive Decline Rapid and not Regained Following Discontinuation of
Acetylecholinesterase Inhibitors - Doctor's Guide, 7/22/02
-
Long-Term Memantine Associated with Significant Cost Reductions in Advanced
Alzheimer's - Doctor's Guide, 7/22/02
Related Searches:
70519
|
|
